Cargando…

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma

Glioma is the most common primary intracranial tumor and is related to poor clinical outcomes. The developments of sensitive markers can be applied to reveal the mechanisms involved in the progression of glioma. This study examined CDCA2 expression in glioma samples and its significance in predictin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Xin, Sun, Zhen-qing, Zhou, Gui-liang, Li, Guo-jun, Deng, Shi-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977301/ https://www.ncbi.nlm.nih.gov/pubmed/35386230 http://dx.doi.org/10.1155/2022/2184867

Ejemplares similares

Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Markers, Disease
Publicado: (2023)

High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity
por: Wang, Yunhan, et al.
Publicado: (2023)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer
por: Li, Siman, et al.
Publicado: (2020)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis
por: Ji, Qian-Kun, et al.
Publicado: (2019)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma
por: Bai, Yuanyuan, et al.
Publicado: (2022)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints
por: Tang, Mengying, et al.
Publicado: (2022)

SDPS-17 COMPREHENSIVE ANALYSIS OF CELL DIVISION CYCLE ASSOCIATED GENE FAMILY EXPRESSION PATTERN AND PROGNOSIS VALUE REVEALS CDCA2 AS A NOVEL ONCOGENE FOR GLIOMA
por: Sun, Wei, et al.
Publicado: (2023)

Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma
por: Hua, Xin, et al.
Publicado: (2020)

Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma
por: Wang, Xiaoxiong, et al.
Publicado: (2021)

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021)

High PYGL Expression Predicts Poor Prognosis in Human Gliomas
por: Zhao, Chang-yi, et al.
Publicado: (2021)

KLF11 Expression Predicts Poor Prognosis in Glioma Patients
por: Xi, Zhuo, et al.
Publicado: (2021)

Increased ski expression levels are associated with a higher risk and poor prognosis in patients with gastrointestinal stromal tumors
por: Wang, Qiu-Shi, et al.
Publicado: (2020)

High APLN Expression Predicts Poor Prognosis for Glioma Patients
por: Lv, Shuangyu, et al.
Publicado: (2022)

High c-Cbl expression in gliomas is associated with tumor progression and poor prognosis
por: JING, ZHITAO, et al.
Publicado: (2016)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

Mechanisms for Bile Acids CDCA- and DCA-Stimulated Hepatic Spexin Expression
por: Lai, Qi, et al.
Publicado: (2022)

A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma
por: Li, Wenle, et al.
Publicado: (2023)

Positive expression of KIF20A indicates poor prognosis of glioma patients
por: Duan, Jia, et al.
Publicado: (2016)

[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2023)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

High LAMC1 expression in glioma is associated with poor prognosis
por: Liu, Jian, et al.
Publicado: (2019)

Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
por: Xin, Bing, et al.
Publicado: (2019)

Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas
por: Wang, Liang, et al.
Publicado: (2012)

CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
por: Guo, Kai, et al.
Publicado: (2022)

High MMP-26 expression in glioma is correlated with poor clinical outcome of patients
por: Guo, Jian-Gui, et al.
Publicado: (2018)

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
por: Lu, Shengkui, et al.
Publicado: (2012)

Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
por: Yuan, Qing, et al.
Publicado: (2021)

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
por: Li, Hao, et al.
Publicado: (2021)

CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia
por: Zhou, Qiang, et al.
Publicado: (2023)

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
por: Sun, Jin-Zhang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f489tpjlok2bkde484s0mt2bau